全身性エリテマトーデス (SLE) は、人体のほぼすべての器官および器官系に影響を及ぼす多全身性の不治の自己免疫疾患です。この状態では免疫系が身体自身の組織を攻撃し、関係する臓器に重大な炎症や組織損傷を引き起こします。関節の腫れ、原因不明の発熱、胸の不快感、脱毛、口内炎、リンパ節の腫れ、ひどい倦怠感、顔の赤い発疹などは、SLE の最も一般的な症状の一部です。
SLE は、世界中で利用可能で有効な治療法の選択肢がほとんどなく、治療が非常に不十分な状態です。GSKのベンリスタ（2011年に米国FDA、2019年に中国のNMPAによって承認）、アストラゼネカのサフネロ（2021年8月にFDAによって承認）、およびRemeGenのテリタシセプト（2021年に中国のNMPAによって承認）が、この適応症で承認された唯一の生物学的療法です。しかし、満たされていない医療ニーズが膨大であることを考慮すると、市場は今後数年間で拡大が予想されます。世界の全身性エリテマトーデス市場は2023年に21億8,000万ドルに達すると予想されており、予測期間中7.52%のCAGRで成長します。
目次
Table of contents
1. Executive Summary
2. Introduction
2.1 Systemic Lupus Erythematosus (SLE): An Overview
2.2 Systemic Lupus Erythematosus (SLE) Segmentation: An Overview
3. Global Market Analysis
3.1 Global Systemic Lupus Erythematosus Market: An Analysis
3.1.1 Global Systemic Lupus Erythematosus Market by Value
3.1.2 Global Systemic Lupus Erythematosus Market by Number of Patients
3.1.3 Global Systemic Lupus Erythematosus Market by Product Type (Biologics, NSAIDs, Antimalarial Drugs, Corticosteroids, Immunosuppressants and Others)
3.1.4 Global Systemic Lupus Erythematosus Market by Route of Administration (Oral, Intravenous and Subcutaneous)
3.1.5 Global Systemic Lupus Erythematosus Market by End User (Hospitals, Drug Lab and Others)
3.1.6 Global Systemic Lupus Erythematosus Market by Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa)
3.2 Global Systemic Lupus Erythematosus Market: Product Analysis
3.2.1 Global Biologics Systemic Lupus Erythematosus Market by Value
3.2.2 Global NSAIDs Systemic Lupus Erythematosus Market by Value
3.2.3 Global Antimalarial Drugs Systemic Lupus Erythematosus Market by Value
3.2.4 Global Corticosteroids Systemic Lupus Erythematosus Market by Value
3.2.5 Global Immunosuppressant Systemic Lupus Erythematosus Market by Value
3.2.6 Global Others Systemic Lupus Erythematosus Market by Value
3.3 Global Systemic Lupus Erythematosus Market: Route of Administration Analysis
3.3.1 Global Oral Systemic Lupus Erythematosus Market by Value
3.3.2 Global Intravenous Systemic Lupus Erythematosus Market by Value
3.3.3 Global Subcutaneous Systemic Lupus Erythematosus Market by Value
3.4 Global Systemic Lupus Erythematosus Market: End User Analysis
3.4.1 Global Hospitals Systemic Lupus Erythematosus Market by Value
3.4.2 Global Drug Lab Systemic Lupus Erythematosus Market by Value
3.4.3 Global Others Systemic Lupus Erythematosus Market by Value
4. Regional Market Analysis
4.1 North America Systemic Lupus Erythematosus Market: An Analysis
4.1.1 North America Systemic Lupus Erythematosus Market by Value
4.1.2 North America Systemic Lupus Erythematosus Market by Region (The US, Canada and Mexico)
4.1.3 The US Systemic Lupus Erythematosus Market by Value
4.1.4 The US Systemic Lupus Erythematosus Market by Number of Patients
4.1.5 Canada Systemic Lupus Erythematosus Market by Value
4.1.6 Mexico Systemic Lupus Erythematosus Market by Value
4.2 Europe Systemic Lupus Erythematosus Market: An Analysis
4.2.1 Europe Systemic Lupus Erythematosus Market by Value
4.2.2 Europe Systemic Lupus Erythematosus Market by Region (UK, Germany, France, Spain, Italy and Rest of Europe)
4.2.3 UK Systemic Lupus Erythematosus Market by Value
4.2.4 Germany Systemic Lupus Erythematosus Market by Value
4.2.5 France Systemic Lupus Erythematosus Market by Value
4.2.6 Spain Systemic Lupus Erythematosus Market by Value
4.2.7 Italy Systemic Lupus Erythematosus Market by Value
4.2.8 Rest of Europe Systemic Lupus Erythematosus Market by Value
4.3 Asia pacific Systemic Lupus Erythematosus Market: An Analysis
4.3.1 Asia pacific Systemic Lupus Erythematosus Market by Value
4.4 Middle East & Africa Systemic Lupus Erythematosus Market: An Analysis
4.4.1 Middle East & Africa Systemic Lupus Erythematosus Market by Value
4.5 Latin America Systemic Lupus Erythematosus Market: An Analysis
4.5.1 Latin America Systemic Lupus Erythematosus Market by Value
5. Impact of COVID-19
5.1 Impact of COVID-19
5.1.1 Impact of COVID-19 on Healthcare
5.1.2 Impact of COVID-19 on Systemic Lupus Erythematosus Market
6. Market Dynamics
6.1 Growth Drivers
6.1.1 Increasing Healthcare Expenditure
6.1.2 Increasing Female Population
6.1.3 Rapid Urbanization
6.1.4 Favorable Government Initiatives
6.1.5 Rising Prevalence of SLE Disease
6.2 Challenges
6.2.1 Stringent Regulatory Environment
6.2.2 High Cost of Drug Development
6.3 Trends
6.3.1 Rising Clinical Trials
6.3.2 Adoption of Stem Cell Therapy
6.3.3 Rising Awareness Among People
7. Competitive Landscape
7.1 The US and China Systemic Lupus Erythematosus Market Players by Marketed Biologics for SLE Treatment
7.2 The US and China Systemic Lupus Erythematosus Market players by Pipeline Biologics for SLE Treatment
8. Company Profiles
8.1 Hoffmann-LA- Roche Ltd.
8.1.1 Business Overview
8.1.2 Operating Segments
8.1.3 Business Strategies
8.2 Pfizer, Inc.
8.2.1 Business Overview
8.2.2 Operating Segments
8.2.3 Business Strategies
8.3 AbbVie, Inc.
8.3.1 Business Overview
8.3.2 Operating Segments
8.3.3 Business Strategies
8.4 Novartis AG
8.4.1 Business Overview
8.4.2 Operating Segments
8.4.3 Business Strategies
8.5 AstraZeneca Plc
8.5.1 Business Overview
8.5.2 Operating Segments
8.5.3 Business Strategies
8.6 GlaxoSmithKline plc
8.6.1 Business Overview
8.6.2 Operating Segments
8.6.3 Business Strategies
8.7 Merck & Co., Inc.
8.7.1 Business Overview
8.7.2 Operating Segments
8.7.3 Business Strategies
8.8 UCB SA
8.8.1 Business Overview
8.8.2 Operating Regions
8.8.3 Business Strategies
8.9 RemeGen Co., Ltd.
8.9.1 Business Overview
8.9.2 Operating Regions
8.9.3 Business Strategies
8.10 Amgen Inc.
8.10.1 Business Overview
8.10.2 Operating Region
8.10.3 Business Strategies
8.11 Biotest AG
8.11.1 Business Overview
8.11.2 Operating Segments
8.11.3 Business Strategies
8.12 Xencor, Inc.
8.12.1 Business Overview
8.12.2 Revenue By Operations
8.12.3 Business Strategies
8.13 Sanofi
8.13.1 Business Overview
8.13.2 Operating Segments
8.13.3 Business Strategies
8.14 Boston Pharmaceuticals
8.14.1 Business Overview
8.14.2 Business Strategies
Table of Figures
Figure 1: Systemic Lupus Erythematosus (SLE) Segmentation
Figure 2: Global Systemic Lupus Erythematosus Market by Value; 2017-2021 (US$ Billion)
Figure 3: Global Systemic Lupus Erythematosus Market by Value; 2022-2026 (US$ Billion)
Figure 4: Global Systemic Lupus Erythematosus Market by Number of Patients; 2020-2021 (Million)
Figure 5: Global Systemic Lupus Erythematosus Market by Number of Patients; 2022-2026 (Million)
Figure 6: Global Systemic Lupus Erythematosus Market by Product Type; 2021 (Percentage, %)
Figure 7: Global Systemic Lupus Erythematosus Market by Route of Administration; 2021 (Percentage, %)
Figure 8: Global Systemic Lupus Erythematosus Market by End User; 2021 (Percentage, %)
Figure 9: Global Systemic Lupus Erythematosus Market by Region; 2021 (Percentage, %)
Figure 10: Global Biologics Systemic Lupus Erythematosus Market by Value; 2017-2021 (US$ Million)
Figure 11: Global Biologics Systemic Lupus Erythematosus Market by Value; 2022-2026 (US$ Million)
Figure 12: Global NSAIDs Systemic Lupus Erythematosus Market by Value; 2017-2021 (US$ Million)
Figure 13: Global NSAIDs Systemic Lupus Erythematosus Market by Value; 2022-2026 (US$ Million)
Figure 14: Global Antimalarial Drugs Systemic Lupus Erythematosus Market by Value; 2017-2021 (US$ Million)
Figure 15: Global Antimalarial Drugs Systemic Lupus Erythematosus Market by Value; 2022-2026 (US$ Million)
Figure 16: Global Corticosteroids Systemic Lupus Erythematosus Market by Value; 2017-2021 (US$ Million)
Figure 17: Global Corticosteroids Systemic Lupus Erythematosus Market by Value; 2022-2026 (US$ Million)
Figure 18: Global Immunosuppressant Systemic Lupus Erythematosus Market by Value; 2017-2021 (US$ Million)
Figure 19: Global Immunosuppressant Systemic Lupus Erythematosus Market by Value; 2022-2026 (US$ Million)
Figure 20: Global Others Systemic Lupus Erythematosus Market by Value; 2017-2021 (US$ Million)
Figure 21: Global Others Systemic Lupus Erythematosus Market by Value; 2022-2026 (US$ Million)
Figure 22: Global Oral Systemic Lupus Erythematosus Market by Value; 2017-2021 (US$ Million)
Figure 23: Global Oral Systemic Lupus Erythematosus Market by Value; 2022-2026 (US$ Billion)
Figure 24: Global Intravenous Systemic Lupus Erythematosus Market by Value; 2017-2021 (US$ Million)
Figure 25: Global Intravenous Systemic Lupus Erythematosus Market by Value; 2022-2026 (US$ Million)
Figure 26: Global Subcutaneous Systemic Lupus Erythematosus Market by Value; 2017-2021 (US$ Million)
Figure 27: Global Subcutaneous Systemic Lupus Erythematosus Market by Value; 2022-2026 (US$ Million)
Figure 28: Global Hospitals Systemic Lupus Erythematosus Market by Value; 2017-2021 (US$ Million)
Figure 29: Global Hospitals Systemic Lupus Erythematosus Market by Value; 2022-2026 (US$ Million)
Figure 30: Global Drug Lab Systemic Lupus Erythematosus Market by Value; 2017-2021 (US$ Million)
Figure 31: Global Drug Lab Systemic Lupus Erythematosus Market by Value; 2022-2026 (US$ Million)
Figure 32: Global Others Systemic Lupus Erythematosus Market by Value; 2017-2021 (US$ Million)
Figure 33: Global Others Systemic Lupus Erythematosus Market by Value; 2022-2026 (US$ Million)
Figure 34: North America Systemic Lupus Erythematosus Market by Value; 2017-2021 (US$ Million)
Figure 35: North America Systemic Lupus Erythematosus Market by Value; 2022-2026 (US$ Million)
Figure 36: North America Systemic Lupus Erythematosus Market by Region; 2021 (Percentage, %)
Figure 37: The US Systemic Lupus Erythematosus Market by Value; 2020-2021 (US$ Million)
Figure 38: The US Systemic Lupus Erythematosus Market by Value; 2022-2026 (US$ Million)
Figure 39: The US Systemic Lupus Erythematosus Market by Number of Patients; 2020-2021 (Thousand)
Figure 40: The US Systemic Lupus Erythematosus Market by Number of Patients; 2022-2026 (Thousand)
Figure 41: Canada Systemic Lupus Erythematosus Market by Value; 2020-2021 (US$ Million)
Figure 42: Canada Systemic Lupus Erythematosus Market by Value; 2022-2026 (US$ Million)
Figure 43: Mexico Systemic Lupus Erythematosus Market by Value; 2020-2021 (US$ Million)
Figure 44: Mexico Systemic Lupus Erythematosus Market by Value; 2022-2026 (US$ Million)
Figure 45: Europe Systemic Lupus Erythematosus Market by Value; 2017-2021 (US$ Million)
Figure 46: Europe Systemic Lupus Erythematosus Market by Value; 2022-2026 (US$ Million)
Figure 47: Europe Systemic Systemic Lupus Erythematosus Market by Region; 2021 (Percentage, %)
Figure 48: UK Systemic Lupus Erythematosus Market by Value; 2020-2021 (US$ Million)
Figure 49: UK Systemic Lupus Erythematosus Market by Value; 2022-2026 (US$ Million)
Figure 50: Germany Systemic Lupus Erythematosus Market by Value; 2020-2021 (US$ Million)
Figure 51: Germany Systemic Lupus Erythematosus Market by Value; 2022-2026 (US$ Million)
Figure 52: France Systemic Lupus Erythematosus Market by Value; 2020-2021 (US$ Million)
Figure 53: France Systemic Lupus Erythematosus Market by Value; 2022-2026 (US$ Million)
Figure 54: Spain Systemic Lupus Erythematosus Market by Value; 2020-2021 (US$ Million)
Figure 55: Spain Systemic Lupus Erythematosus Market by Value; 2022-2026 (US$ Million)
Figure 56: Italy Systemic Lupus Erythematosus Market by Value; 2020-2021 (US$ Million)
Figure 57: Italy Systemic Lupus Erythematosus Market by Value; 2022-2026 (US$ Million)
Figure 58: Rest of Europe Systemic Lupus Erythematosus Market by Value; 2020-2021 (US$ Million)
Figure 59: Rest of Europe Systemic Lupus Erythematosus Market by Value; 2022-2026 (US$ Million)
Figure 60: Asia pacific Systemic Lupus Erythematosus Market by Value; 2017-2021 (US$ Million)
Figure 61: Asia pacific Systemic Lupus Erythematosus Market by Value; 2022-2026 (US$ Million)
Figure 62: Middle East & Africa Systemic Lupus Erythematosus Market by Value; 2017-2021 (US$ Million)
Figure 63: Middle East & Africa Systemic Lupus Erythematosus Market by Value; 2022-2026 (US$ Million)
Figure 64: Latin America Systemic Lupus Erythematosus Market by Value; 2017-2021 (US$ Million)
Figure 65: Latin America Systemic Lupus Erythematosus Market by Value; 2022-2026 (US$ Million)
Figure 66: The US Health Consumption Expenditure as a Percentage of GDP; 2015-2020 (Percentage, %)
Figure 67: Global Female Population of Age Group 15-44; 2005-2020 (Billion)
Figure 68: Global Urban Population as a Share of Total Population; 2016-2021 (Percentage, %)
Figure 69: Hoffmann-La-Roche Ltd. Sales by Business Divisions; 2021 (Percentage, %)
Figure 70: Pfizer Inc. Revenues by Operating Segments; 2021 (Percentage, %)
Figure 71: Abbvie, Inc. Net Revenues by Products; 2021 (Percentage, %)
Figure 72: Novartis AG Net Sales by Segment; 2021 (Percentage, %)
Figure 73: AstraZeneca Plc Total Revenue by Product; 2021 (Percentage, %)
Figure 74: GlaxoSmithKline plc Turnover by Segments; 2021 (Percentage, %)
Figure 75: Merck & Co., Inc. Total Sales by Segments; 2021 (Percentage, %)
Figure 76: UCB SA Net Sales by Region; 2021 (Percentage, %)
Figure 77: RemeGen Co., Ltd. Revenue by Region; 2021 (Percentage, %)
Figure 78: Amgen Inc. Revenue by Region; 2021 (Percentage, %)
Figure 79: Biotest AG Sales by Segment; 2021 (Percentage, %)
Figure 80: Xencor, Inc. Revenue by Operations; 2021 (Percentage, %)
Figure 81: Sanofi Net Sales by segments; 2021 (Percentage, %)
Table 1: The US and China Systemic Lupus Erythematosus Market Players by Marketed Biologics for SLE Treatment
Table 2: The US and China Systemic Lupus Erythematosus Market Players by Pipeline Biologics for SLE Treatment
